\n<\/p>\n
The Nuclear Imaging Market is projected to grow at a CAGR of 12.9% during the forecast period 2024-2031. Nuclear imaging is an advanced imaging technology that produces images by detecting radiation from different parts of the body after administering a radioactive tracer material. This technology is used to diagnose and monitor various diseases, particularly in oncology and cardiology.<\/p>\n
\ud835\udc03\ud835\udc28\ud835\udc30\ud835\udc27\ud835\udc25\ud835\udc28\ud835\udc1a\ud835\udc1d \ud835\udc05\ud835\udc2b\ud835\udc1e\ud835\udc1e \ud835\udc12\ud835\udc1a\ud835\udc26\ud835\udc29\ud835\udc25\ud835\udc1e: https:\/\/www.datamintelligence.com\/download-sample\/nuclear-imaging-market<\/a><\/p>\n \ud835\udc0c\ud835\udc1a\ud835\udc2b\ud835\udc24\ud835\udc1e\ud835\udc2d \ud835\udc13\ud835\udc2b\ud835\udc1e\ud835\udc27\ud835\udc1d\ud835\udc2c:<\/p>\n The growth of the nuclear imaging market is driven by the increasing focus on personalized medicine and advancements in radiotracer technology. Additionally, the rising prevalence of chronic diseases such as cancer and the expanding pharmaceutical industry further enhance market growth.<\/p>\n \ud835\udc13\ud835\udc1e\ud835\udc1c\ud835\udc21\ud835\udc27\ud835\udc28\ud835\udc25\ud835\udc28\ud835\udc20\ud835\udc22\ud835\udc1c\ud835\udc1a\ud835\udc25 \ud835\udc00\ud835\udc1d\ud835\udc2f\ud835\udc1a\ud835\udc27\ud835\udc1c\ud835\udc1e\ud835\udc26\ud835\udc1e\ud835\udc27\ud835\udc2d\ud835\udc2c: Innovations in multimodality imaging systems, such as PET\/CT, SPECT\/CT, PET\/MRI, and PET\/SPECT\/CT, are improving the accuracy of disease detection and treatment monitoring. The expansion of automation and miniaturization of cyclotrons, along with advances in radiochemistry, are making radiotracer production more practical and versatile.<\/p>\n \ud835\udc11\ud835\udc22\ud835\udc2c\ud835\udc22\ud835\udc27\ud835\udc20 \ud835\udc0f\ud835\udc2b\ud835\udc1e\ud835\udc2f\ud835\udc1a\ud835\udc25\ud835\udc1e\ud835\udc27\ud835\udc1c\ud835\udc1e \ud835\udc28\ud835\udc1f \ud835\udc02\ud835\udc1a\ud835\udc27\ud835\udc1c\ud835\udc1e\ud835\udc2b \ud835\udc1a\ud835\udc27\ud835\udc1d \ud835\udc02\ud835\udc1a\ud835\udc2b\ud835\udc1d\ud835\udc22\ud835\udc1a\ud835\udc1c \ud835\udc03\ud835\udc22\ud835\udc2c\ud835\udc1e\ud835\udc1a\ud835\udc2c\ud835\udc1e\ud835\udc2c: Nuclear imaging plays a crucial role in diagnosing and managing these conditions. Studies have shown that nuclear imaging significantly impacts patient management by improving tumor monitoring and response evaluation.<\/p>\n \ud835\udc02\ud835\udc21\ud835\udc1a\ud835\udc25\ud835\udc25\ud835\udc1e\ud835\udc27\ud835\udc20\ud835\udc1e\ud835\udc2c \ud835\udc22\ud835\udc27 \ud835\udc11\ud835\udc1a\ud835\udc1d\ud835\udc22\ud835\udc28\ud835\udc27\ud835\udc2e\ud835\udc1c\ud835\udc25\ud835\udc22\ud835\udc1d\ud835\udc1e \ud835\udc12\ud835\udc2e\ud835\udc29\ud835\udc29\ud835\udc25\ud835\udc32: A major hurdle for the market is the shortage of Tc-99m (Technetium-99), a widely used radioisotope in nuclear medicine scans. This shortage could negatively impact diagnostic imaging procedures worldwide.<\/p>\n \ud835\udc0c\ud835\udc1a\ud835\udc2b\ud835\udc24\ud835\udc1e\ud835\udc2d \ud835\udc12\ud835\udc1e\ud835\udc20\ud835\udc26\ud835\udc1e\ud835\udc27\ud835\udc2d\ud835\udc1a\ud835\udc2d\ud835\udc22\ud835\udc28\ud835\udc27:<\/p>\n By Product Type: Hybrid Pet, Standalone Pet, Hybrid SPECT, Standalone SPECT, Planar Scintigraphy.<\/p>\n By Application: Cardiology, Neurology, Oncology, Others.<\/p>\n By End-User: Hospitals, Research Centers, Academic Centers, Diagnostic Centers, Others.<\/p>\n By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.<\/p>\n \ud835\udc11\ud835\udc1e\ud835\udc2a\ud835\udc2e\ud835\udc1e\ud835\udc2c\ud835\udc2d \ud835\udc1f\ud835\udc28\ud835\udc2b \ud835\udc02\ud835\udc2e\ud835\udc2c\ud835\udc2d\ud835\udc28\ud835\udc26\ud835\udc22\ud835\udc33\ud835\udc1a\ud835\udc2d\ud835\udc22\ud835\udc28\ud835\udc27: https:\/\/www.datamintelligence.com\/customize\/nuclear-imaging-market<\/a><\/p>\n \ud835\udc06\ud835\udc1e\ud835\udc28\ud835\udc20\ud835\udc2b\ud835\udc1a\ud835\udc29\ud835\udc21\ud835\udc22\ud835\udc1c\ud835\udc1a\ud835\udc25 \ud835\udc00\ud835\udc27\ud835\udc1a\ud835\udc25\ud835\udc32\ud835\udc2c\ud835\udc22\ud835\udc2c:<\/p>\n \ud835\udc0d\ud835\udc28\ud835\udc2b\ud835\udc2d\ud835\udc21 \ud835\udc00\ud835\udc26\ud835\udc1e\ud835\udc2b\ud835\udc22\ud835\udc1c\ud835\udc1a \ud835\udc0b\ud835\udc1e\ud835\udc1a\ud835\udc1d\ud835\udc22\ud835\udc27\ud835\udc20 \ud835\udc2d\ud835\udc21\ud835\udc1e \ud835\udc0c\ud835\udc1a\ud835\udc2b\ud835\udc24\ud835\udc1e\ud835\udc2d:<\/p>\n North America holds the largest share of the nuclear imaging market, driven by initiatives such as the American Medical Isotope Production Act (AMIPA) and the Uranium Lease and Take-Back (ULTB) program.<\/p>\n The U.S. Department of Energy (DOE) promotes domestic production of Mo-99, reducing reliance on high-enriched uranium (HEU) for medical isotope production.<\/p>\n Canada is one of the largest producers of Technetium-99m, further boosting the regional market.<\/p>\n Increased awareness and physician recommendations for nuclear medicine procedures are also contributing to market expansion.<\/p>\n \ud835\udc02\ud835\udc28\ud835\udc26\ud835\udc29\ud835\udc1e\ud835\udc2d\ud835\udc22\ud835\udc2d\ud835\udc22\ud835\udc2f\ud835\udc1e \ud835\udc0b\ud835\udc1a\ud835\udc27\ud835\udc1d\ud835\udc2c\ud835\udc1c\ud835\udc1a\ud835\udc29\ud835\udc1e:<\/p>\n The nuclear imaging market is moderately competitive, with both local and global players actively driving innovation and expansion. Major players in the market include:<\/p>\n Bracco Imaging SpA \ud835\udc12\ud835\udc2d\ud835\udc2b\ud835\udc1a\ud835\udc2d\ud835\udc1e\ud835\udc20\ud835\udc22\ud835\udc1c \ud835\udc03\ud835\udc1e\ud835\udc2f\ud835\udc1e\ud835\udc25\ud835\udc28\ud835\udc29\ud835\udc26\ud835\udc1e\ud835\udc27\ud835\udc2d\ud835\udc2c:<\/p>\n Key players in the market are adopting various strategies such as product launches, acquisitions, and collaborations to strengthen their market presence. For instance, in May 2018, Curium expanded its presence in the French PET market by acquiring Cyclopharma\u0092s French commercial and manufacturing operations. <\/p>\n<\/div>\n
Cardinal Health Inc.
GE Healthcare
Koninklijke Philips NV
Siemens Healthineers
Curium
CMR NAVISCAN (GAMMA MEDICA INC.)
Nordion (Canada) Inc.
NTP Radioisotopes SOC
Canon Medical Systems Corporation<\/p>\n